1. The advent of a pan-collagenous CLOVIS POINT for pathotropic targeting and cancer gene therapy, a retrospective
   Erlinda M. Gordon et al, 2023, Frontiers in Molecular Medicine CrossRef
2. Phase I-II study using DeltaRex-G, a tumor-targeted retrovector encoding a cyclin G1 inhibitor for metastatic carcinoma of breast
   Howard W. Bruckner et al, 2023, Frontiers in Molecular Medicine CrossRef